menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Value of Biomarkers in MS Patients

close
The Value of Biomarkers in MS Patients
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Comments
  • Overview

    Dr. Antonio Uccelli discusses the possible near-term treatment future of patients with multiple sclerosis while at ECTRIMS 2015 in Barcelona, Spain, highlighting efforts to personalize each patient’s therapy based on MRI status and use of biomarkers as a means to select evidence-based approaches designed to maximize neuroprotection and reduce the realities of disability and brain atrophy.

    This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

Facebook Comments

Recommended
Details
Comments
  • Overview

    Dr. Antonio Uccelli discusses the possible near-term treatment future of patients with multiple sclerosis while at ECTRIMS 2015 in Barcelona, Spain, highlighting efforts to personalize each patient’s therapy based on MRI status and use of biomarkers as a means to select evidence-based approaches designed to maximize neuroprotection and reduce the realities of disability and brain atrophy.

    This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

Facebook Comments

Programs 5/13/21